Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (511-520 of 622) with videos related to

Pageof 63
Sort By:
Annals of the Rheumatic Diseases|August 19, 2019
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrualSerena Fasano, Antonella Riccardi, Valentina Messiniti, et al.
The Lancet. Rheumatology|January 27, 2024
<sup>68</sup>Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot studyChristina Bergmann, Jörg H W Distler, Christoph Treutlein, et al.
The Journal of Clinical Investigation|May 15, 2024
Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosisThuong Trinh-Minh, Chih-Wei Chen, Cuong Tran Manh, et al.
Rheumatology International|September 15, 2023
Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohortSuhrud Panchawagh, Doskaliuk Bohdana, Masataka Kuwana, et al.
Annals of the Rheumatic Diseases|July 11, 2023
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosisIoannis Parodis, Charlotte Girard-Guyonvarc'h, Laurent Arnaud, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2018
Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group StudyVeronika K Jaeger, Gabriele Valentini, Eric Hachulla, et al.
Annals of the Rheumatic Diseases|February 3, 2011
EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma researchChristian Beyer, Jörg H W Distler, Yannick Allanore, et al.
The Journal of Rheumatology|December 3, 2013
Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control studyEtienne Ghrénassia, Jérome Avouac, Dinesh Khanna, et al.
The Journal of Rheumatology|October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
Journal of Scleroderma and Related Disorders|May 19, 2025
Recommendations for the local management of digital ulcers in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) 'Ad hoc committee'Corrado Campochiaro, Yossra A Suliman, Dilia Giuggioli, et al.
Pageof 63

Showing results (511-520 of 622) with videos related to

Sort By:
Pageof 63
Annals of the Rheumatic Diseases|August 19, 2019
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrualSerena Fasano, Antonella Riccardi, Valentina Messiniti, et al.
The Lancet. Rheumatology|January 27, 2024
<sup>68</sup>Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot studyChristina Bergmann, Jörg H W Distler, Christoph Treutlein, et al.
The Journal of Clinical Investigation|May 15, 2024
Noncanonical WNT5A controls the activation of latent TGF-β to drive fibroblast activation and tissue fibrosisThuong Trinh-Minh, Chih-Wei Chen, Cuong Tran Manh, et al.
Rheumatology International|September 15, 2023
Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohortSuhrud Panchawagh, Doskaliuk Bohdana, Masataka Kuwana, et al.
Annals of the Rheumatic Diseases|July 11, 2023
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosisIoannis Parodis, Charlotte Girard-Guyonvarc'h, Laurent Arnaud, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2018
Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group StudyVeronika K Jaeger, Gabriele Valentini, Eric Hachulla, et al.
Annals of the Rheumatic Diseases|February 3, 2011
EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma researchChristian Beyer, Jörg H W Distler, Yannick Allanore, et al.
The Journal of Rheumatology|December 3, 2013
Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control studyEtienne Ghrénassia, Jérome Avouac, Dinesh Khanna, et al.
The Journal of Rheumatology|October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
Journal of Scleroderma and Related Disorders|May 19, 2025
Recommendations for the local management of digital ulcers in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) 'Ad hoc committee'Corrado Campochiaro, Yossra A Suliman, Dilia Giuggioli, et al.
Pageof 63